Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination.

Derhovanessian E, Theeten H, Hähnel K, Van Damme P, Cools N, Pawelec G.

Vaccine. 2013 Jan 11;31(4):685-90. doi: 10.1016/j.vaccine.2012.11.041.

PMID:
23196209
2.

Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells.

Vieira Braga FA, Hertoghs KM, van Lier RA, van Gisbergen KP.

Eur J Immunol. 2015 Sep;45(9):2433-45. doi: 10.1002/eji.201545495. Review.

3.

Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review.

Weltevrede M, Eilers R, de Melker HE, van Baarle D.

Exp Gerontol. 2016 May;77:87-95. doi: 10.1016/j.exger.2016.02.005. Review.

PMID:
26883338
4.

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, Pawelec G.

Vaccine. 2012 Mar 9;30(12):2060-7. doi: 10.1016/j.vaccine.2012.01.015. Review.

5.

Immunosenescence: Implications for response to infection and vaccination in older people.

Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, Solana R.

Maturitas. 2015 Sep;82(1):50-5. doi: 10.1016/j.maturitas.2015.05.004. Review.

PMID:
26044074
6.

Properties of end-stage human T cells defined by CD45RA re-expression.

Henson SM, Riddell NE, Akbar AN.

Curr Opin Immunol. 2012 Aug;24(4):476-81. doi: 10.1016/j.coi.2012.04.001. Review.

Items per page

Supplemental Content

Support Center